Prof. Satish P. Ramachandra Rao

Prof. Satish P. Ramachandra Rao |Clyto Access

Director, Exosome Research Center,Institute of Public Health, India

Keynote Speaker

Expertise:

Biography:

Dr. Rao received his Ph. D. in Neurochemistry from the Christian Medical College, Vellore, India. He has performed postdoctoral studies in Indian Institute of Science, Bangalore, India. He was recruited to Department of Medicine/Nephrology, Thomas Jefferson University, Philadelphia, USA to work on kidney organ function dysfunction biomarkers specifically in subjects with diabetes. In 2007 he moved to University of California at San Diego School of Medicine, California, USA, as an Assistant Professor of Medicine, where he continued his Kidney disease related work in Nephrology. After setting up 2 independently functional laboratories completely from ground up in these two universities in USA, he changed his focus to Clinical Biomarkers of Acute Kidney Injury in the NIH-funded George O’Brien Center for AKI Research at UC San Diego, as the Director of the Biomarkers Laboratory. He moved to Kolar Medical College in 2016 as Professor and Head of the department of Cell Biology & Molecular Genetics, Director of the Center for Exosome Research and the Research Officer of the University, along with multiple translational research collaborations in about a dozen institutions across the country. He continues his association with his previous institution as a Visiting Professor at University of California, San Diego. Recently he has assumed the leadership of a Bangalore-based consortium to develop programs for preventing dengue (ICMR-INFOSYS Initiative for Dengue Vaccine Trial Site Development), and biomarkers of health and wellness in Indian Population at the interface of Western Medicine and Integrative Medicine. His work has been continuously funded by USA-based public health agencies such as National Institutes of Health, Bethesda, Maryland, Juvenile Diabetes Research Foundation, New York. One of his research interests is developing non-invasive technology platforms, such as urine exosome biomarkers of kidney physiology in health and disease.

,

Related Conferences :

International Diabetes and Degenerative Diseases Conference